Gene silencing by chromatin compaction is integral to establishing and maintaining cell fates. Trimethylated histone 3 lysine 9 (H3K9me3)-marked heterochromatin is reduced in embryonic stem cells compared to differentiated cells. However, the establishment and dynamics of closed regions of chromatin at protein-coding genes, in embryologic development, remain elusive. We developed an antibody-independent method to isolate and map compacted heterochromatin from low-cell number samples. We discovered high levels of compacted heterochromatin, H3K9me3-decorated, at protein-coding genes in early, uncommitted cells at the germ-layer stage, undergoing profound rearrangements and reduction upon differentiation, concomitant with cell type-specific gene expression. Perturbation of the three H3K9me3-related methyltransferases revealed a pivotal role for H3K9me3 heterochromatin during lineage commitment at the onset of organogenesis and for lineage fidelity maintenance.
T he phylotypic period of embryologic development occurs at the onset of organogenesis, when morphological development is most conserved between different species (1-3). The "hourglass" model suggests that cell fate decisions are restricted during the phylotypic period by evolutionarily conserved transcription factor and signaling activities (1) (2) (3) . Limited assay sensitivity and small numbers of cells have made it difficult to investigate chromatin dynamics during the phylotypic period, when cell differentiation initiates extensively in embryos. Current thinking from the embryonic stem (ES) cell model (4) suggests that compacted heterochromatic domains expand as cells mature, helping to establish cell identity (5) (6) (7) (8) (9) (10) (11) . However, these studies did not examine the dynamic events occurring during natural lineage commitment at organogenesis.
Regions of trimethylated histone 3 lysine 9 (H3K9me3)-marked heterochromatin can have a physically condensed structure (12) (13) (14) that serves to repress repeat-rich regions of the genome (7, (15) (16) (17) , including centromeric and telomeric regions (18, 19) , and silence proteincoding genes at facultative heterochromatin (20, 21) . The early lethal in vivo developmental phenotypes associated with the depletion of H3K9me3-related histone methyltransferases (HMTases) (15, 22, 23) support the idea that H3K9me3 controls genome stability and differentiation. Recently, H3K9me3 dynamics at repetitive elements and promoters have been characterized at pregastrula stages (24) . The global heterochromatin reorganization at germlayer stages and during lineage commitment in vivo has not been addressed, and prior studies did not distinguish H3K9me3-decorated regions that are euchromatic from those that are heterochromatic (25) . H3K9me3-enriched domains also impede cell reprogramming and somatic cell nuclear transfer (17, (25) (26) (27) , underscoring the importance of understanding the natural dynamics by which heterochromatic domains restrict cell fates during normal development.
We globally assessed the dynamics of compacted, sonication-resistant heterochromatin (srHC) (25) and H3K9me3 deposition at critical developmental time points in the murine endoderm germ layer and in cells along the descendent hepatic and pancreatic lineages (Fig. 1A and figs. S1, A and B; S2, A to H; and S3, A to F). Because the embryonic starting material has low cell numbers, we developed a sonication-resistant heterochromatin sequencing (srHC-seq) method that is sucrose gradientindependent (25) to detect regions of srHC ( fig. S4 , A to E). We performed srHC-seq in definitive endodermal cells, hepatocytes, and mature beta cells and found similar fractions of the genome in srHC in the three cell types ( fig. S4, F and G) . In all stages, gene expression was anticorrelated with sonication resistance (fig. S4H) Fig. 1D and tables S10 and S11). A similar process is detected in the mesoderm lineage, but not upon differentiation of midbrain neuroepithelium, which is already past the ectoderm stage, into neurons ( fig. S7F and tables S10 and S11).
H3K9me3 and H3K27me3 reside both in srHC and open chromatin, where they decorate regions independently or in combination (25) (fig. S8 , A to C). However, unlike H3K9me3, heterochromatin marked by H3K27me3 was similarly distributed over genes and intergenic regions in definitive endoderm, hepatocytes, and mature beta cells ( fig. S9, A to E) .
We assessed the acquisition of stage-specific transcriptional signatures along the hepatic and pancreatic lineages ( fig. S10, A to E; figs. S13A and S14, A to D; and table S14), whereas constitutively expressed or repressed genes were depleted or decorated by the mark, respectively (Fig. 2B and fig. S13 , B and C). H3K27me3 dynamics at both hepatic and pancreaticspecific genes were also detected, showing loss in development ( fig. S14E ). Of the 1008 and 1249 genes in adult hepatocytes and mature beta cells that fail to be expressed at a higher level in differentiated versus uncommitted cells, but lose H3K9me3, 71% and 74%, respectively, showed increased H3K27me3 levels compared to definitive endoderm (fig S15A) , indicating a compensatory mechanism for maintaining heterochromatin at a subset of genes that remain developmentally silent. Overall, the results show that H3K9me3-marked heterochromatin is transiently deployed in germ-layer cells to repress genes associated with mature cell function and is removed at many sites during differentiation to allow tissue-specific gene expression.
H3K9me3 is established by three main HMTases: Setdb1, Suv39h1, and Suv39h2 (15, 22, 23) . Setdb1 single and Suv39h1/h2 double germline knockouts are associated with early lethal phenotypes (15, 17, 22) . We used FoxA3-Cre to generate endoderm-specific (28, 29) , conditional knockout (KO) mice for Setdb1 (30) (fig. S16A ) and analyzed e11.5 livers. H3K9me3 was modestly reduced in mutant embryos ( fig. S16B ), which showed bleeding in different body regions but no gross morphological differences in the liver structure and cell composition ( fig. S16C ). Single-cell RNAseq on wild-type (wt) e11.5 hepatoblasts revealed three clusters of cell types (clusters 1 to 3, table S15), whose differentially expressed genes were associated with developmental processes, hepatic metabolism, and hematopoiesis, respectively (Fig. 3A and fig. S17, A to E) . Expressed genes in Setdb1 mutant cells more than doubled in cluster 1 compared to wt cells but were reduced in cluster 2 (Fig. 3A) . Setdb1 mutant albuminpositive (Alb+) cells from cluster 2 fail to induce hepatic markers and separate into a distinct subcluster from that of wt Alb+ cells (Fig. 3B and table S15). Adult, conditional Setdb1 mutant livers show occasional hypertrophic hepatocytes ( fig. S16, D and E) that maintain nuclear Setdb1 and H3K9me3 levels, as well as expression of major urinary proteins (MUPs) (fig. S16D) . However, the bulk of Setdb1-negative cells show lower levels of H3K9me3 and no expression of MUPs, in stark contrast to wt livers that uniformly express pericentral MUPs (fig. S16D) fig. S16B and S18A) , the appearance of escaper cells ( fig. S16D, arrows) , and the expression of H3K9me3-related HMTases being higher in definitive endoderm, compared to more specified cells ( fig. S18B ), prompted us to generate an endoderm-specific conditional tripleknockout mutant (TKO) murine strain of all three H3K9me3-related HMTases ( fig. S19, A to F) . Protein analysis showed a clear reduction in Setdb1, Suv39h1 ( fig. S20A ), and Suv39h2 ( fig. S20B ), leading to a marked decrease in H3K9me3, but not in H3K27me3 and H3K9me2 ( fig. S20 , A and C). Single-cell RNA-seq on e11.5 Liv2+ cells revealed that TKO hepatoblasts clustered into a separate group compared to wt and Setdb1 mutant cells (Fig. 4A) , with an overlap of only 43 genes, of nonliver types, up-regulated in common between TKO and Setdb1 mutant cells (table S15) . Indeed, despite expressing albumin ( fig. S20D ), TKO cells did not gain a clear hepatic transcriptional profile ( fig. S20E and table S15 ). One-month-old triple-mutant animals (n = 5) appeared smaller in size compared to control littermates (Fig. 4B) , showing up to a threefold reduction in body weight ( fig. S21A ). TKO livers display inflammatory phenotypes, characterized by a ductular reaction (Fig. 4C) . Genomic analysis ( fig. S21 , B and C) confirmed a substantial loss in srHC and H3K9me3 (Fig. 4D) , which was validated by a global loss of condensed chromatin as seen by electron microscopy (Fig. 4E) . RNAseq data on 1-month-old livers ( fig. S21, D and E) revealed a marked derepression of nonhepatic genes in TKO livers and a failure to induce mature hepatocyte genes such as MUPs ( fig. S22, A and B, and table S16). The latter phenotype, seen also in adult Setdb1 KO livers ( fig. S16D ), indicates secondary effects upon depletion of H3K9me3-related HMTases. Notably, markers associated with chromosomal instability were mostly unaffected ( fig. S22, C to E) . Thus, failure to establish H3K9me3-marked heterochromatin during early development leads to a failure of hepatocyte maturation, even 1 month after birth, and results in expression of inappropriate lineage genes.
Heterochromatin has been defined by biophysical properties more than by repressive histone modifications (25) . We employed an approach whereby srHC is isolated and characterized independently and in correlation with H3K9me3. We found higher levels of heterochromatin at gene bodies in early, uncommitted endodermal and mesodermal cells and observed a developmental loss of H3K9me3 and srHC during cell differentiation in vivo ( fig. S23A ). Genetics of H3K9me3-related HMTase mutant mice highlighted the importance of proper heterochromatin establishment to promote cell differentiation. These findings underscore how epigenetic regulation of chromatin structure controls cell identity in embryogenesis. We propose a role for H3K9me3-marked heterochromatin as an epigenetic contributor to the hourglass model (1-3), working in concert with homeobox proteins (1) and signaling (2) influences, to constrain gene activity during the phylotypic period of embryonic development and guarantee establishment of cell identity.
